Essential fatty acid status in paediatric Crohn's disease: Relationship with disease activity and nutritional status

Alimentary Pharmacology and Therapeutics

Volumn 18, Issue 4, 2003, Pages 433-442

  Trebble, T M ^a   Wootton, S A ^a   May, A ^a   Erlewyn Lajeunesse, M D S ^b   Chakraborty, A ^b   Mullee, M A ^c   Stroud, M A ^a   Beattie, R M ^b  

^a UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

^b SOUTHAMPTON GENERAL HOSPITAL   (United Kingdom)

^c UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ARACHIDONIC ACID; ESSENTIAL FATTY ACID; ICOSAPENTAENOIC ACID; LINOLEIC ACID; LINOLENIC ACID; MEMBRANE PHOSPHOLIPID; PHOSPHATIDYLCHOLINE;

ADOLESCENT; ARTICLE; BODY MASS; CHILDHOOD DISEASE; CLINICAL ARTICLE; CROHN DISEASE; DISEASE ACTIVITY; FAT INTAKE; FATTY ACID BLOOD LEVEL; FEMALE; HUMAN; MALE; NUTRITIONAL STATUS; PRIORITY JOURNAL; PROTEIN CALORIE MALNUTRITION; SCHOOL CHILD;

ADOLESCENT; BODY COMPOSITION; BODY MASS INDEX; C-REACTIVE PROTEIN; CROHN DISEASE; ERYTHROCYTES; FATTY ACIDS, ESSENTIAL; FEMALE; HUMANS; MALE; NUTRITIONAL STATUS; PHOSPHOLIPIDS;

EID: 0042830363     PISSN: 02692813     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2036.2003.01707.x     Document Type: Article

References (34)

1. Cosgrove M, Al Atia RF, Jenkins HR. The epidemiology of paediatric inflammatory bowel disease. Arch Dis Child 1996; 74: 460-1.
2. Harries AD, Jones LA, Heatley RV, Rhodes J. Malnutrition in inflammatory bowel disease: an anthropometric study. Hum Nutr Clin Nutr 1982; 36: 307-13.
3. Griffiths AM, Nguyen P, Smith C, MacMillan JH, Sherman PM. Growth and clinical course of children with Crohn's disease. Gut 1993; 34: 939-43.
4. Kanof ME, Lake AM, Bayless TM. Decreased height velocity in children and adolescents before the diagnosis of Crohn's disease. Gastroenterology 1988; 95: 1523-7.
5. Savage MO, Beattie RM, Camacho-Hubner C, Walker-Smith JA, Sanderson IR. Growth in Crohn's disease. Acta Paediatr Suppl 1999; 88: 89-92.
6. Bremner AR, Beattie RM. Therapy of Crohn's disease in childhood. Expert Opin Pharmacother 2002; 3: 809-25.
7. Fell JM, Paintin M, Arnaud-Battandier F, et al. Mucosal healing and a fall in mucosal pro-inflammatory cytokine mRNA induced by a specific oral polymeric diet in paediatric Crohn's disease. Aliment Pharmacol Ther 2000; 14: 281-9.
8. Heuschkel RB, Menache CC, Megerian JT, Baird AE. Enteral nutrition and corticosteroids in the treatment of acute Crohn's disease in children. J Pediatr Gastroenterol Nutr 2000; 31: 8-15.
9. Beattie RM, Bentsen BS, MacDonald TT. Childhood Crohn's disease and the efficacy of enteral diets. Nutrition 1998; 14: 345-50.
10. British Nutrition Foundation. n-3 Fatty Acids and Health. London: British Nutrition Foundation, 1999.
11. Salati LM, Goodridge AG. Fatty acid synthesis in eukaryotes. In: Vance DE, Vance JE, eds. Biochemistry of Lipids, Lipoproteins and Membranes. New York: Elsevier Science Publishing, 1996: 101-128.
12. Nakamura MT, Cho HP, Xu J, Tang Z, Clarke SD. Metabolism and functions of highly unsaturated fatty acids: an update. Lipids 2001; 36: 961-4.
13. Leichsenring M, Sutterlin N, Less S, Baumann K, Anninos A, Becker K. Polyunsaturated fatty acids in erythrocyte and plasma lipids of children with severe protein-energy malnutrition. Acta Paediatr 1995; 84: 516-20.
14. Houssaini FZ, Foulon T, Iraqi MR, Payen N, Groslambert P. Lipids, lipoproteins, and fatty acids during infantile marasmus in the Fes area of Morocco. Biomed Pharmacother 1999; 53: 278-83.
15. Wolff JA, Margolis S, Bujdoso-Wolff K, Matusick E, MacLean WC Jr. Plasma and red blood cell fatty acid composition in children with protein-calorie malnutrition. Pediatr Res 1984; 18: 162-7.
16. Decsi T, Molnar D, Koletzko B. The effect of under- and overnutrition on essential fatty acid metabolism in childhood. Eur J Clin Nutr 1998; 52: 541-8.
17. Vajreswari A, Narayanareddy K, Rao PS. Fatty acid composition of erythrocyte membrane lipid obtained from children suffering from kwashiorkor and marasmus. Metabolism 1990; 39: 779-82.
18. Cullis PR, Fenske OB, Hope MJ. Physical properties and functional roles of lipids in membranes. In: Vance DE, Vance JE, eds. Biochemistry of Lipids, Lipoproteins and Membranes. New York: Elsevier Science Publishing, 1996: 1-32.
19. Esteve-Comas M, Ramirez M, Fernandez-Banares F, et al. Plasma polyunsaturated fatty acid pattern in active inflammatory bowel disease. Gut 1992; 33: 1365-9.
20. Geerling BJ, Houwelingen AC, Badart-Smook A, Stockbrugger RW, Brummer RJ. The relation between antioxidant status and alterations in fatty acid profile in patients with Crohn's disease and controls. Scand J Gastroenterol 1999; 34: 1108-16.
21. Belluzzi A, Brignola C, Campieri M, Pera A, Boschi S, Miglioli M. Effect of an enteric-coated fish-oil preparation on relapses in Crohn's disease. N Engl J Med 1996; 334: 1557-60.
22. Hyams JS, Ferry GD, Mandel FS, et al. Development and validation of a pediatric Crohn's disease activity index. J Pediatr Gastroenterol Nutr 1991; 12: 439-47.
23. Otley A, Loonen H, Parekh N, Corey M, Sherman PM, Griffiths AM. Assessing activity of pediatric Crohn's disease: which index to use? Gastroenterology 1999; 116: 527-31.
24. Brignola C, Campieri M, Bazzocchi G, Farruggia P, Tragnone A, Lanfranchi GA. A laboratory index for predicting relapse in asymptomatic patients with Crohn's disease. Gastroenterology 1986; 91: 1490-4.
25. Leiper K, Woolner J, Mullan MM, et al. A randomised controlled trial of high versus low long chain triglyceride whole protein feed in active Crohn's disease. Gut 2001; 49: 790-4.
26. Schreiber S, Nikolaus S, Hampe J, et al. Tumour necrosis factor alpha and interleukin 1beta in relapse of Crohn's disease. Lancet 1999; 353: 459-61.
27. Child Growth Foundation. An Approach to Weight Management in Children and Adolescents in Primary Care. London: Child Growth Foundation, 1997.
28. Shaheen SO, Sterne JA, Thompson RL, Songhurst CE, Margetts BM, Burney PG. Dietary antioxidants and asthma in adults: population-based case-control study. Am J Respir Crit Care Med 2001; 164: 1823-8.
29. Folch J, Lees M, Sloane-Stanley GH. A simple method for the isolation and purification of total lipids from animal tissues. J Biol Chem 1957; 226: 497-509.
30. Burdge GC, Wright P, Jones AE, Wootton SA. A method for separation of phosphatidylcholine, triacylglycerol, non-esterified fatty acids and cholesterol esters from plasma by solid-phase extraction. Br J Nutr 2000; 84: 781-7.
31. Levy E, Rizwan Y, Thibault L, et al. Altered lipid profile, lipoprotein composition, and oxidant and antioxidant status in pediatric Crohn's disease. Am J Clin Nutr 2000; 71: 807-15.
32. Lauritsen K, Laursen LS, Bukhave K, Rask-Madsen J. In vivo profiles of eicosanoids in ulcerative colitis, Crohn's colitis, and Clostridium difficile colitis. Gastroenterology 1988; 95: 11-7.
33. Wardle TD, Hall L, Turnberg LA. Use of coculture of colonic mucosal biopsies to investigate the release of eicosanoids by inflamed and uninflamed mucosa from patients with inflammatory bowel disease. Gut 1992; 33: 1644-51.
34. Scrimshaw NS, SanGiovanni JP. Synergism of nutrition, infection, and immunity: an overview. Am J Clin Nutr 1997; 66: 464S-477S.